Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy

Breemen, M.J. van; Rombach, S.M.; Dekker, N.; Poorthuis, B.J.; Linthorst, G.E.; Zwinderman, A.H.; ... ; Hollak, C.E. (2011)

Article / Letter to editor

• Fabry disease
• Globotriaosylsphingosine, LysoGb3
• Enzyme replacement therapy (ERT)

• All authors: Breemen, M.J. van; Rombach, S.M.; Dekker, N.; Poorthuis, B.J.; Linthorst, G.E.; Zwinderman, A.H.; Breunig, F.; Wanner, C.; Aerts, J.M.F.G.; Hollak, C.E.
• Date: 2011-01-31
• Journal: Biochimica et Biophysica Acta: Molecular Basis of Disease
• Volume: 1812
• Issue: 1
• Pages: 70 - 76
• DOI: doi:10.1016/j.bbadis.2010.09.007
• Link: https://www.sciencedirect.com/science/article/pii/S0925443910002073?via=...